Literature DB >> 18553

Suppression by GABAergic drugs of the locomotor stimulation induced by morphine, amphetamine, and apomorphine: evidence for both pre- and post-synaptic inhibition of catecholamine systems.

J Cott, J Engel.   

Abstract

Locomotor stimulation induced in mice by morphine and amphetamine was antagonized by pretreatment with gamma-butyrolactone (GBL) and amino-oxyacetic acid (AOAA) at doses which had little effect on saline treated animals. The effects of morphine and AOAA on the turnover of brain catecholamines (CA) were determined by measuring both the accumulation of dopa after inhibition of central aromatic L-amino acid decarboxylase and by measuring the depletion of noradrenaline (NA) after inhibition of tyrosine hydroxylase by alpha-methyltyrosine (alpha-MT). Morphine and AOAA were found to have opposite effects on CA turnover, i.e. morphine caused an increase and AOAA, a decrease. AOAA also antagonized the morphine-induced increase in CA turnover. These data might suggest that the well documented ability of GABAergic drugs to inhibit the firing of DA-containing neurons may be of importance in explaining the present findings. However, the locomotor stimulation induced by the directly-acting CA agonists, apomorphine and clonidine after pretreatment with reserpine and alpha-MT was also inhibited by the GABAergic drugs. It is therefore concluded that the suppressant effects of the GABAergic agents on hypermotility and not solely mediated by their effects on presynaptic CA mechanisms, but also by a postsynaptic inhibition at some point beyond the CA neurons.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 18553     DOI: 10.1007/BF01257019

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  26 in total

1.  Synaptic mechanisms in the substantia nigra.

Authors:  A Dray; D W Straughan
Journal:  J Pharm Pharmacol       Date:  1976-04       Impact factor: 3.765

2.  Evidence for an accumbens-pallidal pathway in the rat and its possible gabaminergic control.

Authors:  C Pycock; R Horton
Journal:  Brain Res       Date:  1976-07-16       Impact factor: 3.252

3.  Inhibitory effect of gammahydroxybutyric acid and gammaaminobutyric acid on the dopamine cells in the substantia nigra.

Authors:  N E Andén; G Stock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

4.  Increase in brain dopamine after axotomy or treatment with gammahydroxybutyric acid due to elimination of the nerve impulse flow.

Authors:  G Stock; T Magnusson; N E Andén
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

5.  Mechanism of the gamma-hydroxybutyrate-induced increase in brain dopamine and its relationship to "sleep".

Authors:  R H Roth; Y Suhr
Journal:  Biochem Pharmacol       Date:  1970-12       Impact factor: 5.858

6.  Suppression of ethanol-induced locomotor stimulation by GABA-like drugs.

Authors:  J Cott; A Carlsson; J Engel; M Lindqvist
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-12       Impact factor: 3.000

7.  Antagonism of the analeptic activity of thyrotropin-releasing hormone (TRH) by agents which enhance GABA transmission.

Authors:  J Cott; J Engel
Journal:  Psychopharmacology (Berl)       Date:  1977-04-29       Impact factor: 4.530

8.  Biochemical effects of baclofen (beta-parachlorophenyl-GABA) on the dopamine and the noradrenaline in the rat brain.

Authors:  N E Andén; H Wachtel
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1977-02

9.  Studies on the GABA pathway. I. The inhibition of gamma-aminobutyric acid-alpha-ketoglutaric acid transaminase in vitro and in vivo by U-7524 (amino-oxyacetic acid).

Authors:  D P WALLACH
Journal:  Biochem Pharmacol       Date:  1961-02       Impact factor: 5.858

10.  Elevation of brain GABA concentrations with amino-oxyacetic acid; effect on the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats.

Authors:  A R Green; A F Tordoff; M R Bloomfield
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

View more
  20 in total

1.  Interactions between dopamine and GABA in the control of ambulatory activity.

Authors:  A Agmo; C Belzung; M Giordano
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

2.  Differential effects of ethyl (R,S)-nipecotate on the behaviors of highly and minimally aggressive female golden hamsters.

Authors:  M Potegal
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Evidence for a dopaminergic dominance in the 4,alpha-dimethyl-m-tyramine-induced hypermotility in mice.

Authors:  C Rüdeberg
Journal:  Psychopharmacology (Berl)       Date:  1978-12-08       Impact factor: 4.530

Review 4.  Vertebrate GABA receptors.

Authors:  F V DeFeudis
Journal:  Neurochem Res       Date:  1978-06       Impact factor: 3.996

5.  Neurochemical effects of danitracen (WA-355): mechanism of action.

Authors:  H J Hrishi Keshavan; N K Gurbani; P C Dandiya
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

6.  Effect of apomorphine and gabaergic drugs in monkeys pretreated with haloperidol.

Authors:  N Bjørndal; J Gerlach; D E Casey; E Christensson
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

7.  Effects of GABAergic agonists and antagonists on various ethanol-induced behavioral changes.

Authors:  S Liljequist; J Engel
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

8.  The effect of taurine on motor behaviour, body temperature and monoamine metabolism in rat brain.

Authors:  J Garcia de Yebenes Prous; A Carlsson; M A Mena Gomez
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-09       Impact factor: 3.000

9.  Motor activity of rats following intracerebral injections of drugs influencing GABA mechanisms.

Authors:  H Wachtel; N E Andén
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-04       Impact factor: 3.000

Review 10.  Physiological and behavioral studies with muscimol.

Authors:  F V DeFeudis
Journal:  Neurochem Res       Date:  1980-10       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.